Skip to search formSkip to main contentSkip to account menu

BMI 1026

Known as: BMI-1026, BMI1026 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PhenolsPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The Apoptotic Mechanisms of a Novel Cyclin-dependent Kinase Inhibitor, BMI-1026
2010
2010
Analysis of the role of rab11-FIP3 phosphorylation during cytokinesis
Cytokinesis involves abscission of the intracellular bridge between two daughter cells, thus completing mitosis. Membrane traffic… 
2008
2008
BMI-1026 treatment can induce SAHF formation by activation of Erk1/2.
BMI-1026 is a synthetic aminopyrimidine compound that targets cyclin dependent kinases (cdks) and was initially designed as a… 
2008
2008
Aging and Cancer : Direct inhibition of cdks by BMI-1026 can activate Erk1/2 and induce SAHF
2007
2007
Effects of BMI-1026, A Potent CDK Inhibitor, on Murine Oocyte Maturation and Metaphase II Arrest
【Previous studies have shown that BMI-1026 is a potent inhibitor of the cyclin-dependent kinases (cdk). In cell culture, the… 
2003
2003
Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026.
Cyclin-dependent kinases (Cdks) have been attractive targets for the development of anticancer therapeutic agents. In an effort… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)